Megan K. Fah

Megan K. Fah

Auto-generated profile, based on publicly available information

Megan K. Fah

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in BJA Open
Verified
Journal Article
Open access
JEJordan N. Edwards
Jordan N. Edwards
MWMadeline A. Whitney
Madeline A. Whitney
BSBradford B. Smith
Bradford B. Smith
MFMegan K. Fah
Megan K. Fah
SPSkye A. Buckner Petty
Skye A. Buckner Petty
AMAdam J. Milam
Adam J. Milam
This retrospective study evaluated the efficacy and safety of intraoperative methadone compared with short-acting opioids. Patients undergoing cardiac surgery with cardiopulmonary bypass (n=11 967) from 2018 to 2023 from a single health system were categorised into groups based on intraoperative opioid administration: no methadone (Group O), methadone plus other opioids (Group M+O), and methadone only (Group M). Patients in Groups M and M+O had lower mean pain scores until postoperative day (POD) 7 compared with Group O after adjusting for covariates (P<0.01). Both Groups M and M+O had lower total opioid administered compared with Group O for all days POD0–POD6 (all P<0.001). The median number of hours until initial postoperative opioid after surgery was 2.55 (inter-quartile range [IQR]=1.07–5.12), 6.82 (IQR=3.52–12.98), and 7.0 (IQR=3.82–12.95) for Group O, Group M+O, and Group M, respectively. The incidence of postoperative complications did not differ between groups. Intraoperative administration of methadone was associated with better pain control without significant side-effects after cardiac surgery.